| Product NDC: | 50242-134 | 
| Proprietary Name: | Herceptin | 
| Non Proprietary Name: | Trastuzumab | 
| Active Ingredient(s): | & nbsp; Trastuzumab | 
| Administration Route(s): | |
| Dosage Form(s): | KIT | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 50242-134 | 
| Labeler Name: | Genentech, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | BLA103792 | 
| Marketing Category: | BLA | 
| Start Marketing Date: | 19980925 | 
| Package NDC: | 50242-134-68 | 
| Package Description: | 1 KIT in 1 CARTON (50242-134-68) * 20 mL in 1 VIAL, MULTI-DOSE * 20 mL in 1 VIAL | 
| NDC Code | 50242-134-68 | 
| Proprietary Name | Herceptin | 
| Package Description | 1 KIT in 1 CARTON (50242-134-68) * 20 mL in 1 VIAL, MULTI-DOSE * 20 mL in 1 VIAL | 
| Product NDC | 50242-134 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Trastuzumab | 
| Dosage Form Name | KIT | 
| Route Name | |
| Start Marketing Date | 19980925 | 
| Marketing Category Name | BLA | 
| Labeler Name | Genentech, Inc. | 
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |